Source: Annual Congress 2003 - Burden of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Williams, S. Kay (Greenford, Macclesfield, United Kingdom). Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I. Eur Respir J 2003; 22: Suppl. 45, 235

Member's Comments

No comment yet.

Related content which might interest you: Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The economic burden of respiratory diseases: COPD and asthma Source: Eur Respir Monogr 2014; 65: 116-124 Year: 2014 Repeated hospitalizations in patients and chronic respiratory failure due to COPD are best predicted by health status (QoL) and effort tolerance Source: Eur Respir J 2003; 22: Suppl. 45, 575s Year: 2003 Development of a disease specific health status measure for patients with chronic cough Source: Eur Respir J 2002; 20: Suppl. 38, 449s Year: 2002 Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice Source: Eur Respir J, 54 (3) 1901363; 10.1183/13993003.01363-2019 Year: 2019 Evaluation of health related quality of life in patients with stable chronic respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 66s Year: 2004 Frailty in chronic respiratory disease: prevalence and comparison of rehabilitation clinical outcomes Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Impact on patients' health status following early identification of a COPD exacerbation Source: Eur Respir J 2007; 30: 907-913 Year: 2007 Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Impact of stable state symptoms on the future burden of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002 Socioeconomic outcome of subjects experiencing asthma symptoms at work Source: Eur Respir J 2002; 19: 1107-1113 Year: 2002 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Health status and psychological assessments Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 The effect of individual and group education on disease symptoms, pulmonary functions and quality of life in asthma patient Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002 Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Impact of preventing exacerbations on deterioration of health status in COPD Source: Eur Respir J 2004; 23: 698-702 Year: 2004